15 October 2024

Advancements in nanopore sequencing allow ​in-depth characterization of rAAV vector batches comparable to SMRT™ sequencing

Read More

15 October 2024

Qualification of an mRNA expression assay for GOI, stability insights, and process evolution detection

Read More

15 October 2024

Successful capture DoE studies for a range of AAV serotypes to reduce manufacturing costs & accelerate development

Read More

15 October 2024

Development & qualification of potency assay : guidelines and strategy​

Read More

15 October 2024

Assessing device compatibility through assay matrix approach ensures therapeutic consistency & patient welfare

Read More

15 October 2024

Nanopore sequencing grants detailed insights into a ​small molecule’s impact on encapsidated DNA​ composition during manufacturing platform development

Read More

15 October 2024

Successful validation of capsid titer and host-cell derived DNA impurity assays extends our rAAV batch release QC portfolio

Read More

15 October 2024

Modular, scalable AAV purification process for safe vectors & recoveries of up to 50%

Read More

23 July 2024

Advancing AAV production with high-throughput screening and transcriptomics

Read More

20 May 2024

Combination of BMI, DLS and Visual Inspection to resolve particle formation issues in formulations commonly used in gene therapy

Read More

3 May 2024

Transcriptomic Analysis Identifies Differential Expression Patterns in Cellular Stress Response, Signal Transduction, and Extracellular Matrix Proteins During AAV Production

Read More

3 May 2024

Combination of BMI, DLS and Visual Inspection to Resolve Particle Formulation Issues in Formulations Commonly Used in Gene Therapy

Read More